PEOPLE - Cordis makes appointment
This article was originally published in Clinica
Executive Summary
In a move to stay at the forefront of innovation and drug-device combination product development, the J&J interventional vascular technology company Cordis (Miami Lakes, Florida) has appointed Campbell Rogers to the newly-created position of chief technology officer - effective from early July. Dr Rogers was most recently associate professor of medicine at Harvard Medical School (Massachusetts) and director of the cardiac catheterisation laboratory, the Brigham and Women's Hospital (Boston). His diverse expertise includes cardiac device and pharmacologic trials, and cardiac catheterisation clinical research and care.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.